These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5552365)

  • 1. Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac).
    Eichhorn F; Rutenberg A; Kott E
    Clin Chem; 1971 Apr; 17(4):296-300. PubMed ID: 5552365
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
    Routh JI; Bannow RE; Fincham RW; Stoll JL
    Clin Chem; 1971 Sep; 17(9):867-71. PubMed ID: 5571485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Catecholamine excretion in children with neurogenic tumors of the mediastinum].
    Stepanov EA; Bukhny AE; Bol'shakova TD; Lukicheva TI
    Khirurgiia (Mosk); 1972 Jun; 48(6):125-8. PubMed ID: 5043043
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a screening test for L-dopa and its metabolites in urine.
    Routh JI; Bannow RE
    Clin Chem; 1971 Sep; 17(9):872-4. PubMed ID: 5571486
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion of dopa metabolites.
    Kott E; Bornstein B; Eichhorn F
    N Engl J Med; 1971 Feb; 284(7):395. PubMed ID: 5539935
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid procedure for chromatographic isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels.
    Dalmaz Y; Peyrin L
    J Chromatogr; 1978 Jan; 145(1):11-27. PubMed ID: 621235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical investigations in patients with Parkinson's disease treated with L-dopa.
    Jequier E; Dufresne JJ
    Neurology; 1972 Jan; 22(1):15-21. PubMed ID: 5061836
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M
    Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of levodopa in patients with Parkinson's disease. Radioactive and fluorometric assays.
    Morgan JP; Bianchine JR; Spiegel HE; Rivera-Calimlim L; Hersey RM
    Arch Neurol; 1971 Jul; 25(1):39-44. PubMed ID: 5146410
    [No Abstract]   [Full Text] [Related]  

  • 13. The excretion of dihydroxyphenylalanine, dopamine, and dihydroxyphenylacetic acid in neuroblastoma.
    SOURKES TL; DENTON RL; MURPHY GF; CHAVEZ B; SAINT CYR S
    Pediatrics; 1963 Apr; 31():660-8. PubMed ID: 13978424
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimization of the hydrolysis of conjugated L-DOPA, dopamine and dihydroxyphenylacetic acid in human urine for assay by high-performance liquid chromatography with electrochemical detection.
    Tuomainen P; Männistö PT
    Eur J Clin Chem Clin Biochem; 1997 Mar; 35(3):229-35. PubMed ID: 9127745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excreion of DOPA and metabolites by patients with melanoma.
    Voorhess ML
    Cancer; 1970 Jul; 26(1):146-9. PubMed ID: 5424526
    [No Abstract]   [Full Text] [Related]  

  • 16. A fluorometric method combined with thin layer chromatography for the determination of norepinephrine, epinephrine and dopamine in human urine.
    Takahashi S; Gjessing LR
    Clin Chim Acta; 1972 Feb; 36(2):369-78. PubMed ID: 5008799
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary metabolites from rats given L-DOPA.
    Borud O; Midtvedt T; Gjessing LR
    Acta Pharmacol Toxicol (Copenh); 1972; 31(5):540-9. PubMed ID: 4678834
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative fluorimetric determination of urinary dopa and its significance for the diagnosis of neural crest tumours.
    Türler K; Käser H
    Clin Chim Acta; 1971 Mar; 32(1):41-51. PubMed ID: 4328880
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M; Tanabe H; Yano Y; Nakao K
    No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.